Inventor · disambiguated record
Nicole Teusch
Also filed as: TEUSCH NICOLE · TEUSCH NICOLE E
15 granted patents·7 pending applications·59 citations·filing 2006–2018
88Inventor score
Top patents by PatentIndex Score
22 records- 0192US8648069B25-substituted indazoles as kinase inhibitorsAKRITOPOULOU-ZANZE IRINI·Filed 2008·Granted Feb 11, 2014·44 cites·7 claims
- 0284US9163007B25-substituted indazoles as kinase inhibitorsABBVIE INC·Filed 2013·Granted Oct 20, 2015·8 cites·6 claims
- 0377US8445686B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsMACK HELMUT·Filed 2008·Granted May 21, 2013·3 cites·21 claims
- 0475US8895749B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 25, 2014·2 cites·11 claims
- 0572US9291621B2AGER-peptides and use thereofHAHN ALFRED·Filed 2006·Granted Mar 22, 2016·2 cites·9 claims
- 0665US7906120B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)ABBOTT LAB·Filed 2007·Granted Mar 15, 2011·0 cites·21 claims
- 0763US9255146B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 9, 2016·0 cites·6 claims
- 0863US2019233510A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 0961US10040852B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Granted Aug 7, 2018·0 cites·14 claims
- 1058US2015105386A14-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 1154US2011142845A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBOTT LAB·Filed 2010·Application pending·0 cites
- 1254US2017008959A1Ager-peptides and use thereofABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 1351US2010099681A1Substituted 5-aminopyrazoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1450US2006177816A1Cellular RhoGTPase activation assayABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
- 1549US8642595B2Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereofMICHELS MARTIN·Filed 2009·Granted Feb 4, 2014·0 cites·19 claims
- 1649US8551989B2Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereofMICHELS MARTIN·Filed 2009·Granted Oct 8, 2013·0 cites·20 claims
- 1741US9073939B2Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereofMICHELS MARTIN·Filed 2010·Granted Jul 7, 2015·0 cites·8 claims
- 1840US9422263B2Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereofMICHELS MARTIN·Filed 2010·Granted Aug 23, 2016·0 cites·10 claims
- 1936US9018234B2Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereofVAKALOPOULOS ALEXANDROS·Filed 2010·Granted Apr 28, 2015·0 cites·11 claims
- 2035US8604028B2Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereofMICHELS MARTIN·Filed 2010·Granted Dec 10, 2013·0 cites·4 claims
- 2134US2012270905A1Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereofMICHELS MARTIN·Filed 2010·Application pending·0 cites
- 2233US8759341B2Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereofMICHELS MARTIN·Filed 2010·Granted Jun 24, 2014·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →